Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells' Escape from the Bone Marrow Microenvironment
Recent therapeutic advancements have markedly increased the survival rates of individuals with multiple myeloma (MM), doubling survival compared to pre-2000 estimates. This progress, driven by highly effective novel agents, suggests a growing population of MM survivors exceeding the 10-year mark pos...
Gespeichert in:
| Veröffentlicht in: | Cancers 2024-02, Vol.16 (5), p.889 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 5 |
| container_start_page | 889 |
| container_title | Cancers |
| container_volume | 16 |
| creator | Verbruggen, Stefaan W Freeman, Ciara L Freeman, Fiona E |
| description | Recent therapeutic advancements have markedly increased the survival rates of individuals with multiple myeloma (MM), doubling survival compared to pre-2000 estimates. This progress, driven by highly effective novel agents, suggests a growing population of MM survivors exceeding the 10-year mark post-diagnosis. However, contemporary clinical observations indicate potential trends toward more aggressive relapse phenotypes, characterized by extramedullary disease and dominant proliferative clones, despite these highly effective treatments. To build upon these advances, it is crucial to develop models of MM evolution, particularly focusing on understanding the biological mechanisms behind its development outside the bone marrow. This comprehensive understanding is essential to devising innovative treatment strategies. This review emphasizes the role of 3D models, specifically addressing the bone marrow microenvironment and development of extramedullary sites. It explores the current state-of-the-art in MM modelling, highlighting challenges in replicating the disease's complexity. Recognizing the unique demand for accurate models, the discussion underscores the potential impact of these advanced 3D models on understanding and combating this heterogeneous and still incurable disease. |
| doi_str_mv | 10.3390/cancers16050889 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10931336</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A786432139</galeid><sourcerecordid>A786432139</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-eafcfb73cc5761d3ec5502bf8afca1cb4fb513f3894dd97e128e15e303725c1a3</originalsourceid><addsrcrecordid>eNptUk1vEzEQtRCIVqVnbsgSB7iktT3r_TihkpYPqREcyNnyesepK6-d2pug8OtxaClthX2Y0fi9N5rnIeQ1ZycAHTs1OhhMmddMsrbtnpFDwRoxq-uuev4gPyDHOV-zcgB4UzcvyQG0VQNC8kNys5ycd79cWFE4p4s4oM90inQZkt6ip9MV0vNd0KMzmUZLFzv0cdT0u9e5hDl6n9_Ri2z0GqlNcfzD-BgD0oVOKf6kC2dSxLB1KYYRw_SKvLDaZzy-i0dk-enix_zL7PLb56_zs8uZqSqYZqitsX0Dxsim5gOgkZKJ3ralrrnpK9tLDhbarhqGrkEuWuQSgUEjpOEajsiHW931ph9xMKV10l6tkxt12qmonXr8EtyVWsWt4qwDDlAXhfd3CinebDBPanTZlIl1wLjJSnSyrlterC_Qt0-g13GTQplvj5JVMR7EP9RKe1Qu2Fgam72oOmvaugLBYa918h9UuQOWXyjOWlfqjwint4RidM4J7f2QnKn9pqgnm1IYbx56c4__uxfwGwlWupY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2955431732</pqid></control><display><type>article</type><title>Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells' Escape from the Bone Marrow Microenvironment</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Verbruggen, Stefaan W ; Freeman, Ciara L ; Freeman, Fiona E</creator><creatorcontrib>Verbruggen, Stefaan W ; Freeman, Ciara L ; Freeman, Fiona E</creatorcontrib><description>Recent therapeutic advancements have markedly increased the survival rates of individuals with multiple myeloma (MM), doubling survival compared to pre-2000 estimates. This progress, driven by highly effective novel agents, suggests a growing population of MM survivors exceeding the 10-year mark post-diagnosis. However, contemporary clinical observations indicate potential trends toward more aggressive relapse phenotypes, characterized by extramedullary disease and dominant proliferative clones, despite these highly effective treatments. To build upon these advances, it is crucial to develop models of MM evolution, particularly focusing on understanding the biological mechanisms behind its development outside the bone marrow. This comprehensive understanding is essential to devising innovative treatment strategies. This review emphasizes the role of 3D models, specifically addressing the bone marrow microenvironment and development of extramedullary sites. It explores the current state-of-the-art in MM modelling, highlighting challenges in replicating the disease's complexity. Recognizing the unique demand for accurate models, the discussion underscores the potential impact of these advanced 3D models on understanding and combating this heterogeneous and still incurable disease.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers16050889</identifier><identifier>PMID: 38473251</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antigens ; Biology ; Bone marrow ; Central nervous system ; Clinical trials ; Comparative analysis ; Evolution ; Immunotherapy ; Lymph nodes ; Medical research ; Microenvironments ; Multiple myeloma ; Phenotypes ; Plasma ; Plasma cells ; Review</subject><ispartof>Cancers, 2024-02, Vol.16 (5), p.889</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 by the authors. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c443t-eafcfb73cc5761d3ec5502bf8afca1cb4fb513f3894dd97e128e15e303725c1a3</cites><orcidid>0000-0002-6662-4356 ; 0000-0002-2321-1367</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10931336/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10931336/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38473251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Verbruggen, Stefaan W</creatorcontrib><creatorcontrib>Freeman, Ciara L</creatorcontrib><creatorcontrib>Freeman, Fiona E</creatorcontrib><title>Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells' Escape from the Bone Marrow Microenvironment</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>Recent therapeutic advancements have markedly increased the survival rates of individuals with multiple myeloma (MM), doubling survival compared to pre-2000 estimates. This progress, driven by highly effective novel agents, suggests a growing population of MM survivors exceeding the 10-year mark post-diagnosis. However, contemporary clinical observations indicate potential trends toward more aggressive relapse phenotypes, characterized by extramedullary disease and dominant proliferative clones, despite these highly effective treatments. To build upon these advances, it is crucial to develop models of MM evolution, particularly focusing on understanding the biological mechanisms behind its development outside the bone marrow. This comprehensive understanding is essential to devising innovative treatment strategies. This review emphasizes the role of 3D models, specifically addressing the bone marrow microenvironment and development of extramedullary sites. It explores the current state-of-the-art in MM modelling, highlighting challenges in replicating the disease's complexity. Recognizing the unique demand for accurate models, the discussion underscores the potential impact of these advanced 3D models on understanding and combating this heterogeneous and still incurable disease.</description><subject>Antigens</subject><subject>Biology</subject><subject>Bone marrow</subject><subject>Central nervous system</subject><subject>Clinical trials</subject><subject>Comparative analysis</subject><subject>Evolution</subject><subject>Immunotherapy</subject><subject>Lymph nodes</subject><subject>Medical research</subject><subject>Microenvironments</subject><subject>Multiple myeloma</subject><subject>Phenotypes</subject><subject>Plasma</subject><subject>Plasma cells</subject><subject>Review</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptUk1vEzEQtRCIVqVnbsgSB7iktT3r_TihkpYPqREcyNnyesepK6-d2pug8OtxaClthX2Y0fi9N5rnIeQ1ZycAHTs1OhhMmddMsrbtnpFDwRoxq-uuev4gPyDHOV-zcgB4UzcvyQG0VQNC8kNys5ycd79cWFE4p4s4oM90inQZkt6ip9MV0vNd0KMzmUZLFzv0cdT0u9e5hDl6n9_Ri2z0GqlNcfzD-BgD0oVOKf6kC2dSxLB1KYYRw_SKvLDaZzy-i0dk-enix_zL7PLb56_zs8uZqSqYZqitsX0Dxsim5gOgkZKJ3ralrrnpK9tLDhbarhqGrkEuWuQSgUEjpOEajsiHW931ph9xMKV10l6tkxt12qmonXr8EtyVWsWt4qwDDlAXhfd3CinebDBPanTZlIl1wLjJSnSyrlterC_Qt0-g13GTQplvj5JVMR7EP9RKe1Qu2Fgam72oOmvaugLBYa918h9UuQOWXyjOWlfqjwint4RidM4J7f2QnKn9pqgnm1IYbx56c4__uxfwGwlWupY</recordid><startdate>20240222</startdate><enddate>20240222</enddate><creator>Verbruggen, Stefaan W</creator><creator>Freeman, Ciara L</creator><creator>Freeman, Fiona E</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6662-4356</orcidid><orcidid>https://orcid.org/0000-0002-2321-1367</orcidid></search><sort><creationdate>20240222</creationdate><title>Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells' Escape from the Bone Marrow Microenvironment</title><author>Verbruggen, Stefaan W ; Freeman, Ciara L ; Freeman, Fiona E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-eafcfb73cc5761d3ec5502bf8afca1cb4fb513f3894dd97e128e15e303725c1a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antigens</topic><topic>Biology</topic><topic>Bone marrow</topic><topic>Central nervous system</topic><topic>Clinical trials</topic><topic>Comparative analysis</topic><topic>Evolution</topic><topic>Immunotherapy</topic><topic>Lymph nodes</topic><topic>Medical research</topic><topic>Microenvironments</topic><topic>Multiple myeloma</topic><topic>Phenotypes</topic><topic>Plasma</topic><topic>Plasma cells</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Verbruggen, Stefaan W</creatorcontrib><creatorcontrib>Freeman, Ciara L</creatorcontrib><creatorcontrib>Freeman, Fiona E</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Verbruggen, Stefaan W</au><au>Freeman, Ciara L</au><au>Freeman, Fiona E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells' Escape from the Bone Marrow Microenvironment</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2024-02-22</date><risdate>2024</risdate><volume>16</volume><issue>5</issue><spage>889</spage><pages>889-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Recent therapeutic advancements have markedly increased the survival rates of individuals with multiple myeloma (MM), doubling survival compared to pre-2000 estimates. This progress, driven by highly effective novel agents, suggests a growing population of MM survivors exceeding the 10-year mark post-diagnosis. However, contemporary clinical observations indicate potential trends toward more aggressive relapse phenotypes, characterized by extramedullary disease and dominant proliferative clones, despite these highly effective treatments. To build upon these advances, it is crucial to develop models of MM evolution, particularly focusing on understanding the biological mechanisms behind its development outside the bone marrow. This comprehensive understanding is essential to devising innovative treatment strategies. This review emphasizes the role of 3D models, specifically addressing the bone marrow microenvironment and development of extramedullary sites. It explores the current state-of-the-art in MM modelling, highlighting challenges in replicating the disease's complexity. Recognizing the unique demand for accurate models, the discussion underscores the potential impact of these advanced 3D models on understanding and combating this heterogeneous and still incurable disease.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38473251</pmid><doi>10.3390/cancers16050889</doi><orcidid>https://orcid.org/0000-0002-6662-4356</orcidid><orcidid>https://orcid.org/0000-0002-2321-1367</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2072-6694 |
| ispartof | Cancers, 2024-02, Vol.16 (5), p.889 |
| issn | 2072-6694 2072-6694 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10931336 |
| source | MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
| subjects | Antigens Biology Bone marrow Central nervous system Clinical trials Comparative analysis Evolution Immunotherapy Lymph nodes Medical research Microenvironments Multiple myeloma Phenotypes Plasma Plasma cells Review |
| title | Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells' Escape from the Bone Marrow Microenvironment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A30%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utilizing%203D%20Models%20to%20Unravel%20the%20Dynamics%20of%20Myeloma%20Plasma%20Cells'%20Escape%20from%20the%20Bone%20Marrow%20Microenvironment&rft.jtitle=Cancers&rft.au=Verbruggen,%20Stefaan%20W&rft.date=2024-02-22&rft.volume=16&rft.issue=5&rft.spage=889&rft.pages=889-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers16050889&rft_dat=%3Cgale_pubme%3EA786432139%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2955431732&rft_id=info:pmid/38473251&rft_galeid=A786432139&rfr_iscdi=true |